Abstract
The preceding excerpt is from the preface to a tome that exemplifies integrative medicine, written by the preeminent hematologist and sickle cell researcher, Samir K. Ballas, M.D. Dr. Ballas was one of the first physicians to publish objective information on the management problems for patients, healthcare providers, and loved ones dealing with sickle cell pain. By unabashedly using awkward, embarrassing terms such as prejudice, stereotyping, mistreatment and neglect to describe the problems encountered by the older sickle cell patient, Dr. Ballas helped shepherd in the much-needed, multi-disciplinary team approach in managing sickle cell pain and sickle cell disease (Epstein et al. 2006; Ballas 2005; Ballas 1995; Ballas 1990). This chapter is dedicated to Dr. Ballas who has devoted his professional life to sickle cell patients while sharing his time, generosity, and wisdom with any medical specialty interested in studying any aspect of sickle cell disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Amrolia, P. J., Almeida, A., Davies, S. C., & Roberts, I. A. (2003a). Therapeutic challenges in childhood sickle cell disease. Part 2: a problem-orientated approach. British Journal Haematology, 120, 737–743.
Amrolia, P. J., Almeida, A., Halsey, C., Roberts, I. A., & Davies, S. C. (2003b). Therapeutic challenges in childhood sickle cell disease. Part 1: current and future treatment options. British Journal Haematology, 120, 725–736.
Ballas, S. K. (1990). Treatment of pain in adults with sickle cell disease. American Journal of Hematology, 34, 49–54.
Ballas, S. K. (1995). The sickle cell painful crisis in adults: phases and objective signs. Hemoglobin, 19, 323–333.
Ballas, S. K. (1997). Management of sickle pain. Current Opinion in Hematology, 4, 104–111.
Ballas, S. K. (1998). Sickle cell pain (p. ix). Seattle: International Association for the Study of Pain Press.
Ballas, S. K. (2005). Pain management of sickle cell disease. Hematology/Oncology Clinics of North America, 19, 785–802.
Ballas, S. K. (2008). Meperidine for acute sickle cell pain in the emergency department: revisited controversy. Annals of Emergency Medicine, 51, 217.
Ballas, S. K., & Marcolina, M. J. (2006). Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia. Transfusion, 46, 105–110.
Ballas, S. K., & Mohandas, N. (1996). Pathophysiology of vaso-occlusion. Hematology/Oncology Clinics of North America, 10, 1221–1239.
Ballas, S. K., Cai, S. P., Gabuzda, T., & Chehab, F. F. (1997). Molecular basis of asymptomatic beta-thalassemia major in an African American individual. American Journal of Medical Genetics, 69, 196–199.
Ballas, S. K., Barton, F. B., Waclawiw, M. A., Swerdlow, P., Eckman, J. R., Pegelow, C. H., Koshy, M., Barton, B. A., & Bonds, D. R. (2006). Hydroxyurea and sickle cell anemia: effect on quality of life. Health and Quality of Life Outcomes, 4, 59.
Barakat, L. P., Patterson, C. A., Weinberger, B. S., Simon, K., Gonzalez, E. R., & Dampier, C. (2007). A prospective study of the role of coping and family functioning in health outcomes for adolescents with sickle cell disease. Journal of Pediatric Hematology/Oncology, 29, 752–760.
Bardakdjian-Michau, J. (2003). Neonatal detection of sickle cell disease. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction (Paris), 32(1), S61–S64.
Beuzard, Y. (1996). Towards gene therapy of hemoglobinopathies. Seminars in Hematology, 33, 43–52.
Blaylock, B. (1996). Sickle cell leg ulcers. Medsurg Nursing, 5, 41–43.
Brousseau, D. C., McCarver, D. G., Drendel, A. L., Divakaran, K., & Panepinto, J. A. (2007). The effect of CYP2D6 polymorphisms on the response to pain treatment for pediatric sickle cell pain crisis. Jornal de Pediatria, 150, 623–626.
Carvalho, K. S., & Garg, B. P. (2002). Arterial strokes in children. Neurologic Clinics, 20, 1079–1100. vii.
Charache, S. (1996). Treatment of sickling disorders. Current Opinion in Hematology, 3, 139–144.
Chen, S. H., Liang, D. C., Lin, H. C., Cheng, S. Y., Chen, L. J., & Liu, H. C. (2005). Auditory and visual toxicity during deferoxamine therapy in transfusion-dependent patients. Journal of Pediatric Hematology/Oncology, 27, 651–653.
Chiodo, A. A., Alberti, P. W., Sher, G. D., Francombe, W. H., & Tyler, B. (1997). Desferrioxamine ototoxicity in an adult transfusion-dependent population. The Journal of Otolaryngology, 26, 116–122.
Chulamokha, L., Scholand, S. J., Riggio, J. M., Ballas, S. K., Horn, D., & DeSimone, J. A. (2006). Bloodstream infections in hospitalized adults with sickle cell disease: a retrospective analysis. American Journal of Hematology, 81, 723–728.
Cordner, S., & De, C. K. (2003). Musculoskeletal manifestations of hemoglobinopathies. Current Opinion in Rheumatology, 15, 44–47.
De Franceschi, L., Saadane, N., Trudel, M., et al. (1994). Treatment with oral clotrimazole blocks Ca2 + -mediated K + transport and reverses erythrocyte dehydration in transgenic SAD mice: a model for therapy of sickle cell disease. The Journal of Clinical Investigation, 93, 1670–1676.
Dickerhoff, R., & von, R. A. (1995). Pain crises in patients with sickle cell diseases. Pathogenesis, clinical aspects, therapy. Klinische Pädiatrie, 207, 321–325.
Dimashkieh, H., Choe, J., & Mutema, G. (2003). Renal medullary carcinoma: a report of 2 cases and review of the literature. Archives of Pathology & Laboratory Medicine, 127, e135–e138.
Dumaplin, C. A. (2006). Avoiding admission for afebrile pediatric sickle cell pain: pain management methods. Journal of Pediatric Health Care, 20, 115–122.
Eccleston, C., Yorke, L., Morley, S., Williams, A. C., & Mastroyannopoulou, K. (2003). Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database System Reviews, 99, 157–65. CD003968.
Embury, S. H. (1986). The clinical pathophysiology of sickle cell disease. Annual Review of Medicine, 37, 361–376.
Epstein, K., Yuen, E., Riggio, J. M., Ballas, S. K., & Moleski, S. M. (2006). Utilization of the office, hospital and emergency department for adult sickle cell patients: a five-year study. Journal of the National Medical Association, 98, 1109–1113.
Erhan, E., Inal, M. T., Aydinok, Y., Balkan, C., & Yegul, I. (2007). Tramadol infusion for the pain management in sickle cell disease: a case report. Paediatric Anaesthesia, 17, 84–86.
Fosdal, M. B., & Wojner-Alexandrov, A. W. (2007). Events of hospitalization among children with sickle cell disease. Journal of Pediatric Nursing, 22, 342–346.
Fung, E. B., Harmatz, P., Milet, M., Ballas, S. K., De, C. L., Hagar, W., Owen, W., Olivieri, N., Smith-Whitley, K., Darbari, D., Wang, W., & Vichinsky, E. (2007). Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: a report from the multi-center study of iron overload. American Journal of Hematology, 82, 255–265.
Gaziev, J., & Lucarelli, G. (2003). Stem cell transplantation for hemoglobinopathies. Current Opinion in Pediatrics, 15, 24–31.
Halsey, C., & Roberts, I. A. (2003). The role of hydroxyurea in sickle cell disease. British Journal Haematology, 120, 177–186.
Hebbel, R. P. (1985). Auto-oxidation and a membrane-associated ‘Fenton reagent’: a possible explanation for development of membrane lesions in sickle erythrocytes. Clinics in Haematology, 14, 129–140.
Herrick, J. B. (1910). Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. Archives of Internal Medicine, 6, 517–521.
Huang, J., Zou, Z., Kim-Shapiro, D. B., Ballas, S. K., & King, S. B. (2003). Hydroxyurea analogues as kinetic and mechanistic probes of the nitric oxide producing reactions of hydroxyurea and oxyhemoglobin. Journal of Medicinal Chemistry, 46, 3748–3753.
Hungerford, D. S., & Lennox, D. W. (1985). The importance of increased intraosseous pressure in the development of osteonecrosis of the femoral head: implications for treatment. The Orthopedic Clinics of North America, 16, 635–654.
Jacob, E., Miaskowski, C., Savedra, M., Beyer, J. E., Treadwell, M., & Styles, L. (2006). Changes in sleep, food intake, and activity levels during acute painful episodes in children with sickle cell disease. Journal of Pediatric Nursing, 21, 23–34.
Kaul, D. K., Fabry, M. E., & Nagel, R. L. (1996). The pathophysiology of vascular obstruction in the sickle syndromes. Blood Reviews, 10, 29–44.
Kerle, K. K., & Nishimura, K. D. (1996). Exertional collapse and sudden death associated with sickle cell trait. American Family Physician, 54, 237–240.
Kooy, A., de Heide, L. J., ten Tije, A. J., Mulder, A. H., Tanghe, H. L., Kluytmans, J. A., & Michiels, J. J. (1996). Vertebral bone destruction in sickle cell disease: infection, infarction or both. The Netherlands Journal of Medicine, 48, 227–231.
Labie, D., & Elion, J. (1996a). Sickle cell anemia: model of variability in expression of monogenic disease. Archives of Pediatrics, 3, 101–103.
Labie, D., & Elion, J. (1996b). Sequence polymorphisms of potential functional relevance in the beta-globin gene locus. Hemoglobin, 20, 85–101.
Laird, L., Dezateux, C., & Anionwu, E. N. (1996). Neonatal screening for sickle cell disorders: what about the carrier infants? British Medical Journal, 313, 407–411.
Lane, P. A. (1996). Sickle cell disease. Pediatric Clinics of North America, 43, 639–664.
Lefevre-Witier, P. (1985). An anthropological perspective on the epidemiology of hemoglobin defects and glucose-6-phosphate dehydrogenase deficiencies in the northern half of the African continent. Progress in Clinical and Biological Research, 194, 367–397.
Mankad, V. N. (2001). Exciting new treatment approaches for pathyphysiologic mechanisms of sickle cell disease. Pediatric Pathology & Molecular Medicine, 20, 1–13.
Marchant, W. A., & Walker, I. (2003). Anaesthetic management of the child with sickle cell disease. Paediatric Anaesthesia, 13, 473–489.
Mitchell, M. J., Lemanek, K., Palermo, T. M., Crosby, L. E., Nichols, A., & Powers, S. W. (2007). Parent perspectives on pain management, coping, and family functioning in pediatric sickle cell disease. Clinical Pediatrics (Philadelphia), 46, 311–319.
Molitierno, J. A., Jr. (2003). Carson CC, III: urologic manifestations of hematologic disease sickle cell, leukemia, and thromboembolic disease. The Urologic Clinics of North America, 30, 49–61.
Moore, C. M., Ehlayel, M., Leiva, L. E., & Sorensen, R. U. (1996). New concepts in the immunology of sickle cell disease. Annals of Allergy, Asthma & Immunology, 76, 385–400.
Murray, M. J., & Evans, P. (1996). Sudden exertional death in a soldier with sickle cell trait. Military Medicine, 161, 303–305.
Naffakh, N., & Danos, O. (1996). Gene transfer for erythropoiesis enhancement. Molecular Medicine Today, 2, 343–348.
Nowak-Gottl, U., Straeter, R., Sebire, G., & Kirkham, F. (2003). Antithrombotic drug treatment of pediatric patients with ischemic stroke. Paediatric Drugs, 5, 167–175.
Owusu-Ofori, S., & Riddington, C. (2002). Splenectomy versus conservative management for acute sequestration crises in people with sickle cell disease. Cochrane Database System Reviews, PubMed, CD003425.
Pandit, H. M. (1996). Viruses–a conundrum. Physiological Chemistry and Physics and Medical NMR, 28, 29–33.
Rao, V. M., Sebes, J. I., Steiner, R. M., & Ballas, S. K. (1991). Noninvasive diagnostic imaging in hemoglobinopathies. Hematology/Oncology Clinics of North America, 5, 517–533.
Scheinman, J. I. (2003). Sickle cell disease and the kidney. Seminars in Nephrology, 23, 66–76.
Serjeant, G. R. (1996). The role of preventive medicine in sickle cell disease. The Watson Smith lecture. Journal of the Royal College of Physicians of London, 30, 37–41.
Setty, B. N., Kulkarni, S., Dampier, C. D., & Stuart, M. J. (2001). Fetal hemoglobin in sickle cell anemia: relationship to erythrocyte adhesion markers and adhesion. Blood, 97, 2568–2573.
Sing, C. F., Boerwinkle, E., & Moll, P. P. (1985). Strategies for elucidating the phenotypic and genetic heterogeneity of a chronic disease with a complex etiology. Progress in Clinical and Biological Research, 194, 39–66.
Smith, T. G., Ayi, K., Serghides, L., Mcallister, C. D., & Kain, K. C. (2002). Innate immunity to malaria caused by Plasmodium falciparum. Clinical and Investigative Medicine, 25, 262–272.
Steinberg, M. H. (1996). Modulation of the phenotypic diversity of sickle cell anemia. Hemoglobin, 20, 1–19.
Steiner, R. M., Mitchell, D. G., Rao, V. M., Murphy, S., Rifkin, M. D., Burk, D. L., Jr., Ballas, S. K., & Vinitski, S. (1990). Magnetic resonance imaging of bone marrow: diagnostic value in diffuse hematologic disorders. Magnetic Resonance Quarterly, 6, 17–34.
Stinson, J., & Naser, B. (2003). Pain management in children with sickle cell disease. Paediatric Drugs, 5, 229–241.
Styles, L. A., & Vichinsky, E. P. (1996). Ototoxicity in hemoglobinopathy patients chelated with desferrioxamine. Journal of Pediatric Hematology/Oncology, 18, 42–45.
Terk, M. R., Zee, C. S., Colletti, P. M., & Haywood, L. J. (1996). The application of magnetic resonance techniques to the evaluation of the patient with sickle-cell disease. Biomedical Instrumentation & Technology, 30, 349–353.
Walco, G. A., & Dampier, C. D. (1987). Chronic pain in adolescent patients. Journal of Pediatric Psychology, 12, 215–225.
Wald, E. R. (1985). Risk factors for osteomyelitis. The American Journal of Medicine, 78, 206–212.
Weatherall, D. J. (1985). WWJRCJB: The developmental genetics of human hemoglobin. Progress in Clinical and Biological Research, 191, 3–25.
Weatherall, D. J., Old, J. M., Thein, S. L., Wainscoat, J. S., & Clegg, J. B. (1985). Prenatal diagnosis of the common haemoglobin disorders. Journal of Medical Genetics, 22, 422–430.
Yang, Y. M., & Pace, B. (2001). Pharmacologic induction of fetal hemoglobin synthesis: cellular and molecular mechanisms. Pediatric Pathology & Molecular Medicine, 20, 87–106.
Zago, M. A., & Costa, F. F. (1985). Hereditary haemoglobin disorders in Brazil. Transactions of the Royal Society of Tropical Medicine and Hygiene, 79, 385–388.
Acknowledgments
The authors would like to thank Dr. Samir K. Ballas, Dr. Johnson Haynes, Jr., Director, USA Sickle Center, Univ. of South Alabama College of Medicine, Dr. William D. Morrison, Director of Musculoskeletal (MSK) Radiology, Jefferson Medical College, Philadelphia and Dr. Carlton Dampier, Director, Marian Anderson SCC Hematology/Oncology, St. Christopher’s Hospital for Children, Philadelphia for sharing their expertise and materials in the preparation of this chapter.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Armstead, V.E., D’Souza, G. (2011). Sickle Cell Pain. In: McClain, B., Suresh, S. (eds) Handbook of Pediatric Chronic Pain. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0350-1_11
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0350-1_11
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0349-5
Online ISBN: 978-1-4419-0350-1
eBook Packages: MedicineMedicine (R0)